Mishra Seema, Bhatnagar Sushma, Gupta Deepak, Goyal Gaurav Nirvani, Agrawal Ravi, Jain Roopesh, Chauhan Himanshu
Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. mseema17@ yahoo.co.in
Am J Hosp Palliat Care. 2009 Jun-Jul;26(3):159-64. doi: 10.1177/1049909108330032. Epub 2009 Jan 30.
Mechanical ventilation in cancer patients is a critical issue The present prospective descriptive study was designed (1) to assess the patient population needing respirator support in ward setting at a premier state-run oncology institute in India, (2) to observe and analyze the course of their disease while on respirator, and (3) to coordinate better quality of life measures in cancer patients at the institute based on the present study's outcomes.
Beginning from March 2005 to March 2006, all cancer patients who were connected to respirator in the wards were enrolled in the current study. Our anesthesiology department at the cancer institute also has primary responsibility for airway management and mechanical ventilation in high dependency units of oncology wards. Preventilation variables in cancer patients were assessed to judge the futility of mechanical ventilation in ward setting. Subsequently, patients were observed for disease course while on respirator. Final outcome with its etio-pathogenesis was correlated with predicted futility of mechanical ventilation.
Over a period of 1 year, 132 (46 men and 86 women) cancer patients with median age 40 years (range 1-75 years) were connected to respirator in oncology wards. Based on the preventilation variables and indications for respirator support, right prediction of medical futility and hospital discharge was made in 77% of patients. Underestimation and overestimation of survival to hospital discharge was made in 10% cases and 13% cases, respectively.
Based on preventilation variables, prediction of outcome in cancer patients needing respirator support can be made in 77% cases. This high probability of prediction can be used to educate patients, and their families and primary physicians, for well-informed and documented advance directives, formulated and regularly revised DNAR policies, and judicious use of respirator support for better quality-of-life outcomes.
癌症患者的机械通气是一个关键问题。本前瞻性描述性研究旨在:(1)评估印度一家一流国营肿瘤研究所病房中需要呼吸支持的患者群体;(2)观察和分析他们在使用呼吸机期间的疾病进程;(3)根据本研究结果,在该研究所协调改善癌症患者的生活质量措施。
从2005年3月至2006年3月,所有在病房中使用呼吸机的癌症患者均纳入本研究。该癌症研究所的麻醉科还主要负责肿瘤病房高依赖单元的气道管理和机械通气。评估癌症患者的预通气变量,以判断病房环境中机械通气的无效性。随后,观察患者在使用呼吸机期间的疾病进程。最终结局及其病因发病机制与机械通气的预测无效性相关。
在1年的时间里,132例(46例男性和86例女性)中位年龄为40岁(范围1 - 75岁)的癌症患者在肿瘤病房使用了呼吸机。根据预通气变量和呼吸支持指征,77%的患者对医疗无效性和出院情况做出了正确预测。分别有10%和13%的病例对出院生存率估计过低和过高。
基于预通气变量,77%的需要呼吸支持的癌症患者的结局可以被预测。这种高预测概率可用于教育患者及其家属和初级医生,以制定明智且有记录的预先指示、制定并定期修订不进行心肺复苏政策,以及明智地使用呼吸支持以获得更好的生活质量结局。